首页> 外文OA文献 >Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults

【2h】

Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults

机译：创新的延长释放口腔碱化配方，允许持续的尿液pH随着每日两次施用：健康成人的随机试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
C. Guittet; C. Roussel-Maupetit; M. A. Manso-Silván; F. Guillaumin; F. Vandenhende; L. A. Granier;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类
入库时间 2022-08-20 22:05:17

相似文献

外文文献
专利

1. Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults [J] . C. Guittet, C. Roussel-Maupetit, M. A. Manso-Silván, Scientific reports. . 2020,第1期

机译：创新的延长释放口腔碱化配方，允许持续的尿液pH随着每日两次施用：健康成人的随机试验
2. PHARMACODYNAMIC EVALUATION OF ADV7103, AN INNOVATIVE PROLONGED-RELEASE ORAL ALKALISING FORMULATION [J] . Guittet Catherine, Manso Maria A., Vandenhende Francois, Pediatric nephrology: journal of the International Pediatric Nephrology Association . 2017,第9期

机译：ADV7103的药效学评估，一种创新的延长释放口腔碱化制剂
3. EFFICACY AND ACCEPTABILITY OF ADV7103, AN INNOVATIVE PROLONGED-RELEASE ORAL ALKALISING FORMULATION IN DISTAL RENAL TUBULAR ACIDOSIS (DRTA) PATIENTS [J] . Bertholet-thomas Aurelia, Guittet Catherine, Manso Maria A., Pediatric nephrology: journal of the International Pediatric Nephrology Association . 2017,第9期

机译：ADV7103的功效和可接受性，在远端肾小管酸中毒（DRTA）患者中的一种创新延长释放口腔碱化制剂
4. PHARMACOKINETIC EVALUATION OF KETOROLAC TROMETHAMINE SUSTAINED-RELEASE PELLET FORMULATION AFTER ORAL ADMINISTRATION IN BEAGLE DOGS [C] . Guk Hyun Jo, Sung-Joo Hwang, Sun Hang Cho Proceedings of the 29th Annual Meeting of the Controlled Release Society . 2002

机译：小剂量口服给药后酮咯酸对苯三胺缓释微丸制剂的药动学评价
5. Product formulations and in vitro - in vivo evaluation of (1) Topical insect repellent formulations against mosquitoes; (2) Oral sustained release formulations of cefaclor and pentoxifylline in adults [D] . Chou, Joyce Tian-wei 1996

机译：产品配方和体外-体内评价（1）局部驱蚊剂对付蚊子；（2）成人头孢克洛和己酮可可碱的口服缓释制剂
6. Bioavailability of oxycodone after administration of a new prolonged-release once-daily tablet formulation in healthy subjects in comparison to an established twice-daily tablet [O] . Bernhard Scheidel, Martina A. Maritz, Yves J. Gschwind, -1

机译：与已确定的每日两次片剂相比羟考酮在健康受试者中每天服用一种新的每日一次缓释片剂制剂后的生物利用度
7. Pharmacokinetics and pharmacodynamic effects of sustained release formulation of urapidil (BKU) in healthy subjects. Results of repeated oral administration. [O] . Yuichi KOIKE, Naoko HINO, Kyoichi OHASHI, 1987

机译：尿布（BKU）在健康受试者中持续释放制剂的药代动力学和药效作用。重复口服给药的结果。

Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults

著录项

相似文献

相关主题

期刊订阅